Which of the following is NOT a listed long-acting insulin analog?

Prepare for the Glucose Management Test with interactive quizzes featuring multiple choice questions, hints, and detailed explanations. Boost your confidence and be exam-ready!

Multiple Choice

Which of the following is NOT a listed long-acting insulin analog?

Explanation:
Long-acting insulin analogs are designed to provide a steady basal level by altering how the insulin is absorbed or acted in the body. Degludec offers ultra-long action, Detemir provides relatively flat, around 24-hour coverage, and Glargine is formulated for about a full day of effect. Regular insulin, on the other hand, is a short-acting human insulin. It begins to work about 30 minutes after injection, peaks in roughly 2–4 hours, and lasts about 6–8 hours, making it suitable for mealtime control rather than basal, continuous coverage. Therefore, Regular insulin is not a long-acting insulin analog.

Long-acting insulin analogs are designed to provide a steady basal level by altering how the insulin is absorbed or acted in the body. Degludec offers ultra-long action, Detemir provides relatively flat, around 24-hour coverage, and Glargine is formulated for about a full day of effect. Regular insulin, on the other hand, is a short-acting human insulin. It begins to work about 30 minutes after injection, peaks in roughly 2–4 hours, and lasts about 6–8 hours, making it suitable for mealtime control rather than basal, continuous coverage. Therefore, Regular insulin is not a long-acting insulin analog.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy